Position in NVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$297,924
+$56,121 QoQ
Shares Held
1,901
+20.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,139
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quotient Wealth Partners, LLC holds $16,322,859 across 12 Drug Manufacturers - General names. NVS ranks #10 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,676 | $4,409,105 | |
| 2 | JNJ |
Johnson & Johnson
|
13,597 | $3,453,230 | |
| 3 | ABBV |
AbbVie Inc.
|
10,682 | $2,688,018 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,346 | $1,329,461 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
10,395 | $1,313,304 | |
| 6 | AMGN |
Amgen Inc
|
2,323 | $841,204 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
10,296 | $593,255 | |
| 8 | PFE |
Pfizer Inc
|
20,928 | $503,946 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $297,924 | 1,901 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $241,803 | 1,583 | Shares | Sole | 2026-04-16 | |
| No filing history on record for this holder in this stock. | ||||||